南卫股份: 南卫股份2025年半年度报告摘要

Core Viewpoint - Jiangsu Nanfang Medical Co., Ltd. reported a decline in net profit and total profit for the first half of 2025 compared to the same period in 2024, indicating potential challenges in the company's financial performance [4]. Company Overview - The company code is 603880, and it is listed on the Shanghai Stock Exchange under the name Nanfang Medical [3]. - As of the end of the reporting period, the total assets amounted to approximately 986.99 million yuan, a decrease of 6.58% from the previous year [3]. Financial Performance - The operating revenue for the reporting period was approximately 306.08 million yuan, reflecting a slight increase of 1.39% compared to 301.87 million yuan in the same period last year [4]. - The total profit for the period was approximately -13.45 million yuan, a significant decrease of 773.56% from a profit of 1.99 million yuan in the previous year [4]. - The net profit attributable to shareholders was approximately -12.97 million yuan, down 1,363.32% from 1.03 million yuan in the previous year [4]. - The net profit after deducting non-recurring gains and losses was approximately -15.40 million yuan, a decrease of 730.84% from 2.44 million yuan in the previous year [4]. - The basic earnings per share were -0.045 yuan, a decline of 1,225.00% from 0.004 yuan in the previous year [5]. Shareholder Information - As of the end of the reporting period, the total number of shareholders was 14,462 [7]. - The largest shareholder, Li Ping, holds 41.12% of the shares, with 118,841,048 shares, of which 82,400,000 are pledged [6]. - Other significant shareholders include Xu Dong (4.48%), Li Yongping (3.33%), and Li Yongzhong (2.80%) [6].